Compounds > piperaquine
Page last updated: 2024-09-03

piperaquine and puromycin

piperaquine has been researched along with puromycin in 1 studies

Compound Research Comparison

Studies
(piperaquine)		Trials
(piperaquine)		Recent Studies (post-2010)
(piperaquine)		Studies
(puromycin)		Trials
(puromycin)		Recent Studies (post-2010) (puromycin)
6382274975,8281311

Protein Interaction Comparison

ProteinTaxonomypiperaquine (IC50)puromycin (IC50)
30S ribosomal protein S6Escherichia coli K-120.9
30S ribosomal protein S7Escherichia coli K-120.9
50S ribosomal protein L15Escherichia coli K-120.9
50S ribosomal protein L10Escherichia coli K-120.9
50S ribosomal protein L11Escherichia coli K-120.9
50S ribosomal protein L7/L12Escherichia coli K-120.9
50S ribosomal protein L19Escherichia coli K-120.9
50S ribosomal protein L1Escherichia coli K-120.9
50S ribosomal protein L20Escherichia coli K-120.9
50S ribosomal protein L27Escherichia coli K-120.9
50S ribosomal protein L28Escherichia coli K-120.9
50S ribosomal protein L29Escherichia coli K-120.9
50S ribosomal protein L31Escherichia coli K-120.9
50S ribosomal protein L31 type BEscherichia coli K-120.9
50S ribosomal protein L32Escherichia coli K-120.9
50S ribosomal protein L33Escherichia coli K-120.9
50S ribosomal protein L34Escherichia coli K-120.9
50S ribosomal protein L35Escherichia coli K-120.9
50S ribosomal protein L36Escherichia coli K-120.9
30S ribosomal protein S10Escherichia coli K-120.9
30S ribosomal protein S11Escherichia coli K-120.9
30S ribosomal protein S12Escherichia coli K-120.9
30S ribosomal protein S13Escherichia coli K-120.9
30S ribosomal protein S16Escherichia coli K-120.9
30S ribosomal protein S18Escherichia coli K-120.9
30S ribosomal protein S19Escherichia coli K-120.9
30S ribosomal protein S20Escherichia coli K-120.9
30S ribosomal protein S2Escherichia coli K-120.9
30S ribosomal protein S3Escherichia coli K-120.9
30S ribosomal protein S4Escherichia coli K-120.9
30S ribosomal protein S5Escherichia coli K-120.9
30S ribosomal protein S8Escherichia coli K-120.9
30S ribosomal protein S9Escherichia coli K-120.9
50S ribosomal protein L13Escherichia coli K-120.9
50S ribosomal protein L14Escherichia coli K-120.9
50S ribosomal protein L16Escherichia coli K-120.9
50S ribosomal protein L23Escherichia coli K-120.9
30S ribosomal protein S15Escherichia coli K-120.9
50S ribosomal protein L17Escherichia coli K-120.9
50S ribosomal protein L21Escherichia coli K-120.9
50S ribosomal protein L30Escherichia coli K-120.9
50S ribosomal protein L6Escherichia coli K-120.9
30S ribosomal protein S14Escherichia coli K-120.9
30S ribosomal protein S17Escherichia coli K-120.9
30S ribosomal protein S1Escherichia coli K-120.9
50S ribosomal protein L18Escherichia coli K-120.9
Puromycin-sensitive aminopeptidaseHomo sapiens (human)6.075
50S ribosomal protein L2Escherichia coli K-120.9
50S ribosomal protein L3Escherichia coli K-120.9
50S ribosomal protein L24Escherichia coli K-120.9
50S ribosomal protein L4Escherichia coli K-120.9
50S ribosomal protein L22Escherichia coli K-120.9
50S ribosomal protein L5Escherichia coli K-120.9
30S ribosomal protein S21Escherichia coli K-120.9
50S ribosomal protein L25Escherichia coli K-120.9
50S ribosomal protein L36 2Escherichia coli K-120.9

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avery, VM; Baell, JB; Ban, K; Beveridge, JG; Blundell, S; Charman, SA; Chavchich, M; Chiu, FCK; Creek, D; Cuellar, ME; Dahlin, JL; Diab, S; Dingjan, T; Duffy, S; Edstein, MD; Ellis, K; Fletcher, S; Harjani, JR; Huang, F; Lucantoni, L; Marfurt, J; Noviyanti, R; Price, RN; Ralph, SA; Shi, DH; Strasser, JM; Teguh, S; Walters, MA; Wirjanata, G; Xue, L1

Other Studies

1 other study(ies) available for piperaquine and puromycin

ArticleYear
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
    Journal of medicinal chemistry, 2019, 03-14, Volume: 62, Issue:5

    Topics: Animals; Antimalarials; Chloroquine; Drug Resistance; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Plasmodium; Species Specificity; Structure-Activity Relationship; Triazines

2019